Natural history and outcome of optic pathway gliomas in children

Pediatric Blood and Cancer

Volumn 53, Issue 7, 2009, Pages 1231-1237

  Nicolin, Gary ^a,b   Parkin, Patricia ^a,b   Mabbott, Donald ^a,b   Hargrave, Darren ^a,b   Bartels, Ute ^a,b   Tabori, Uri ^a,b   Rutka, James ^a,b   Buncic, J Raymond ^a,b   Bouffet, Eric ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diagnosis; Low grade gliomas; Neurofibromatosis type 1; Optic pathway; Progression free survival; Treatment; Visual outcome

Indexed keywords

CARBOPLATIN; ETOPOSIDE; LOMUSTINE; PROCARBAZINE; TIOGUANINE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEUROFIBROMATOSIS; OPTIC NERVE GLIOMA; PERIPHERAL VISION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; TUMOR BIOPSY; ADOLESCENT; CHRONIC BRAIN DISEASE; DISEASE COURSE; DISEASE FREE SURVIVAL; FOLLOW UP; MENTAL DEFICIENCY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RETROSPECTIVE STUDY; SKULL IRRADIATION; SURVIVAL; VISUAL DISORDER;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN DAMAGE, CHRONIC; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; LOMUSTINE; MALE; MENTAL RETARDATION; NEUROFIBROMATOSIS 1; OPTIC NERVE GLIOMA; PROCARBAZINE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THIOGUANINE; TREATMENT OUTCOME; VINBLASTINE; VINCRISTINE; VISION DISORDERS;

EID: 70449713820     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22198     Document Type: Article

References (24)

1. Fouladi M, Wallace D, Langston JW, et al. Survival and functional outcome of children with hypothalamic/chiasmatic tumors. Cancer 2003;97:1084-1092.
2. Cappelli C, Grill J, Raquin M, et al. Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era. Arch Dis Child 1998;79:334-338.
3. Grabenbauer GG, Schuchardt U, Buchfelder M, et al. Radiation therapy of optico-hypothalamic gliomas (OHG) - Radiographic response, vision and late toxicity. Radiother Oncol 2000;54:239-245.
4. Taveras JM, Mount LA, Wood EH. The value of radiation therapy in the management of glioma of the optic nerves and chiasm. Radiology 1956;66:518-528.
5. Sutton LN, Molloy PT, Sernyak H, et al. Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg 1995;83:583-589.
6. Astrup J. Natural history and clinical management of optic pathway glioma. Br J Neurosurg 2003;17:327-335.
7. Hoffman HJ, Humphreys RP, Drake JM, et al. Optic pathway/hypothalamic gliomas: A dilemma in management. Pediatr Neurosurg 1993;19:186-195.
8. Medlock MD, Scott RM. Optic chiasm astrocytomas of childhood. 2. Surgical management. Pediatr Neurosurg 1997;27:129-136.
9. Aquino VM, Fort DW, Kamen BA. Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: A phase II study. J Neurooncol 1999;41:255-259.
10. Laithier V, Grill J, Le Deley MC, et al. Progression-free survival in children with optic pathway tumors: Dependence on age and the quality of the response to chemotherapy - Results of the first French prospective study for the French Society of Pediatric Oncology. J Clin Oncol 2003;21:4572-4578.
11. Moghrabi A, Friedman HS, Burger PC, et al. Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy. J Neurosurg 1993;79:223-227.
12. Packer RJ, Ater J, Allen J, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 1997;86:747-754.
13. Petronio J, Edwards MS, Prados M, et al. Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg 1991;74:701-708.
14. Holladay JT. Visual acuity measurements. J Cataract Refract Surg 2004;30:287-290.
15. http://www.who.int/blindness/Change%20the%20Definition%20-of%20Blindness. pdf [accessed December 18, 2008].
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
17. Dutton JJ. Gliomas of the anterior visual pathway. Surv Ophthalmol 1994;38:427-452.
18. Grill J, Laithier V, Rodriguez D, et al. When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre. Eur J Pediatr 2000;159:692-696.
19. Grill J, Couanet D, Cappelli C, et al. Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol 1999;45:393-396.
20. Sharif S, Ferner R, Birch JM, et al. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: Substantial risks after radiotherapy. J Clin Oncol 2006;24:2570-2575.
21. de Haas V, Grill J, Raquin MA, et al. Relapses of optic pathway tumors after first-line chemotherapy. Pediatr Blood Cancer 2009;52:575-580.
22. Jenkin D, Angyalfi S, Becker L, et al. Optic glioma in children: Surveillance, resection, or irradiation? Int J Radiat Oncol Biol Phys 1993;25:215-225.
23. Gayre GS, Scott IU, Feuer W, et al. Long-term visual outcome in patients with anterior visual pathway gliomas. J Neuroophthalmol 2001;21:1-7.
24. Kelly JP, Weiss AH. Comparison of pattern visual-evoked potentials to perimetry in the detection of visual loss in children with optic pathway gliomas. J AAPOS 2006;10:298-306.